VIOLET Tablet 20 mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Bionex Co., Ltd.
MFDS item code 201100821 · Notified 2011.02.22
This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension
Essential hypertension is a condition where blood pressure is persistently high, putting strain on the cardiovascular system. This medication controls essential hypertension by acting to dilate blood vessels or lower blood pressure. This helps prevent damage to the heart or blood vessels and reduces the risk of serious complications such as stroke or myocardial infarction. It helps maintain stable blood pressure in patients, thereby supporting overall health. Therefore, it is used to treat essential hypertension.
(Adults) The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day, if possible (e.g., in the morning). For patients who may have intravascular volume depletion (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. (Elderly patients) No dose adjustment is necessary when administering this drug to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. (Patients with renal impairment) The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. (Patients with hepatic impairment) No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.
(Children) Safety and efficacy in children have not been established.
This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, if pregnancy is confirmed, it should be discontinued immediately. Patients with allergies to any components of this medication, those who are pregnant or breastfeeding, patients undergoing kidney dialysis, patients with severe liver disorders, patients with bile duct obstruction, patients with lactose intolerance, etc. should not take this medication. Patients with reduced blood volume or salt, patients with decreased kidney function, patients with renovascular hypertension, and those at risk for hyperkalemia should use this medication cautiously, and blood pressure, kidney function, and electrolyte levels should be monitored frequently during treatment. Additionally, caution should be taken when performing high-risk tasks such as working at heights or driving, as dizziness may occur. While taking this medication, side effects such as dizziness, headache, chest pain, indigestion, muscle pain, and rash may occur, and if severe side effects arise, immediate consultation with a physician is necessary. If gastrointestinal symptoms such as chronic diarrhea or weight loss persist, stop taking this medication and consult a healthcare professional. This medication can interact with potassium-sparing diuretics, potassium supplements, lithium, and non-steroidal anti-inflammatory drugs, so if other medications are being taken, be sure to inform the healthcare professional. For pregnant women, there is serious risk to the fetus, so if pregnancy is confirmed, immediately stop taking this medication and regularly monitor fetal status. Breastfeeding individuals may experience adverse effects in infants, so if there are plans to breastfeed or if currently breastfeeding, consult a healthcare professional regarding this medication. Safety for children has not been established; therefore, it is advisable not to use this medication in children. Elderly individuals may experience slower drug metabolism and elimination; therefore, caution is required during administration, and in cases of overdose, symptoms such as hypotension and palpitations may appear, requiring immediate treatment.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius. This helps to preserve the medication's effectiveness for a longer duration.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Bionex Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.